136 related articles for article (PubMed ID: 9079822)
1. Immunomodulatory effects of a plasmid expressing B7-2 on human immunodeficiency virus-1-specific cell-mediated immunity induced by a plasmid encoding the viral antigen.
Tsuji T; Hamajima K; Ishii N; Aoki I; Fukushima J; Xin KQ; Kawamoto S; Sasaki S; Matsunaga K; Ishigatsubo Y; Tani K; Okubo T; Okuda K
Eur J Immunol; 1997 Mar; 27(3):782-7. PubMed ID: 9079822
[TBL] [Abstract][Full Text] [Related]
2. Interference with CD28, CD80, CD86 or CD152 in collagen-induced arthritis. Limited role of IFN-gamma in anti-B7-mediated suppression of disease.
Tellander AC; Pettersson U; Runström A; Andersson M; Michaëlsson E
J Autoimmun; 2001 Aug; 17(1):39-50. PubMed ID: 11488636
[TBL] [Abstract][Full Text] [Related]
3. [Effect of B7-2 expression plasmid on the specific immune response induced by HBV DNA vaccine].
Wang Y; Jin Q; Song C; Sun B
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Dec; 16(4):370-2. PubMed ID: 12665909
[TBL] [Abstract][Full Text] [Related]
4. Nucleic acid vaccine-induced immune responses require CD28 costimulation and are regulated by CTLA4.
Horspool JH; Perrin PJ; Woodcock JB; Cox JH; King CL; June CH; Harlan DM; St Louis DC; Lee KP
J Immunol; 1998 Mar; 160(6):2706-14. PubMed ID: 9510170
[TBL] [Abstract][Full Text] [Related]
5. Expression and contribution of B7-1 (CD80) and B7-2 (CD86) in the early immune response to Leishmania major infection.
Elloso MM; Scott P
J Immunol; 1999 Jun; 162(11):6708-15. PubMed ID: 10352289
[TBL] [Abstract][Full Text] [Related]
6. Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CTLA-4 costimulatory molecules.
Yang G; Hellström KE; Hellström I; Chen L
J Immunol; 1995 Mar; 154(6):2794-800. PubMed ID: 7533183
[TBL] [Abstract][Full Text] [Related]
7. Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses.
Roy M; Aruffo A; Ledbetter J; Linsley P; Kehry M; Noelle R
Eur J Immunol; 1995 Feb; 25(2):596-603. PubMed ID: 7533092
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-12 and B7.1 co-stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumors.
Zitvogel L; Robbins PD; Storkus WJ; Clarke MR; Maeurer MJ; Campbell RL; Davis CG; Tahara H; Schreiber RD; Lotze MT
Eur J Immunol; 1996 Jun; 26(6):1335-41. PubMed ID: 8647214
[TBL] [Abstract][Full Text] [Related]
9. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation.
Tao X; Constant S; Jorritsma P; Bottomly K
J Immunol; 1997 Dec; 159(12):5956-63. PubMed ID: 9550393
[TBL] [Abstract][Full Text] [Related]
10. CTLA-4 blockade augments human T lymphocyte-mediated suppression of lung tumor xenografts in SCID mice.
Sabel MS; Hess SD; Egilmez NK; Conway TF; Chen FA; Bankert RB
Cancer Immunol Immunother; 2005 Oct; 54(10):944-52. PubMed ID: 15846492
[TBL] [Abstract][Full Text] [Related]
11. B7 co-stimulatory requirements differ for induction of immune responses by DNA, protein and recombinant pox virus vaccination.
Santra S; Barouch DH; Sharpe AH; Letvin NL
Eur J Immunol; 2000 Sep; 30(9):2650-9. PubMed ID: 11009099
[TBL] [Abstract][Full Text] [Related]
12. HIV-1-specific cell-mediated immunity is enhanced by co-inoculation of TCA3 expression plasmid with DNA vaccine.
Tsuji T; Fukushima J; Hamajima K; Ishii N; Aoki I; Bukawa H; Ishigatsubo Y; Tani K; Okubo T; Dorf ME; Okuda K
Immunology; 1997 Jan; 90(1):1-6. PubMed ID: 9038705
[TBL] [Abstract][Full Text] [Related]
13. A mutant B7-1/Ig fusion protein that selectively binds to CTLA-4 ameliorates anti-tumor DNA vaccination and counters regulatory T cell activity.
Chakrabarti R; Zhou ZF; Chang Y; Prud'homme GJ
Vaccine; 2005 Aug; 23(37):4553-64. PubMed ID: 15919138
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of cell-mediated immunity against HIV-1 induced by coinnoculation of plasmid-encoded HIV-1 antigen with plasmid expressing IL-12.
Tsuji T; Hamajima K; Fukushima J; Xin KQ; Ishii N; Aoki I; Ishigatsubo Y; Tani K; Kawamoto S; Nitta Y; Miyazaki J; Koff WC; Okubo T; Okuda K
J Immunol; 1997 Apr; 158(8):4008-13. PubMed ID: 9103472
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
Jiang W; Ren L; Jin N
J Virol Methods; 2007 Dec; 146(1-2):266-73. PubMed ID: 17868910
[TBL] [Abstract][Full Text] [Related]
16. Immunoinhibitory DNA vaccine protects against autoimmune diabetes through cDNA encoding a selective CTLA-4 (CD152) ligand.
Prud'homme GJ; Chang Y; Li X
Hum Gene Ther; 2002 Feb; 13(3):395-406. PubMed ID: 11860706
[TBL] [Abstract][Full Text] [Related]
17. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules.
Mauri D; Wyss-Coray T; Gallati H; Pichler WJ
J Immunol; 1995 Jul; 155(1):118-27. PubMed ID: 7541409
[TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma and interleukin-10 inhibit antigen presentation by Langerhans cells for T helper type 1 cells by suppressing their CD80 (B7-1) expression.
Ozawa H; Aiba S; Nakagawa ; Tagami H
Eur J Immunol; 1996 Mar; 26(3):648-52. PubMed ID: 8605933
[TBL] [Abstract][Full Text] [Related]
19. B7-1 but not B7-2 efficiently costimulates CD8+ T lymphocytes in the P815 tumor system in vitro.
Gajewski TF
J Immunol; 1996 Jan; 156(2):465-72. PubMed ID: 8543795
[TBL] [Abstract][Full Text] [Related]
20. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines.
Iwasaki A; Stiernholm BJ; Chan AK; Berinstein NL; Barber BH
J Immunol; 1997 May; 158(10):4591-601. PubMed ID: 9144471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
